Opinion on Pharmaceutical Manufacturers in South Korea

Published within

« | 1 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

South Korea: further price cuts threaten local pharma

With high drug expenditure and a social health insurance system struggling to keep up, South Korea is risking the future of local generics manufacturers in a bid to contain rising costs. Adding to an abundance of existing drug price cuts, Datamonitor believes that this latest plan to reduce the prices of generics will substantially slow market growth in the country.

Published By Datamonitor
16 Aug 2011

« | 1 | » »|

No help is available.